Delivery Order SPE2DB22D1017-SPE2DB23FE7CJ
- Not listed
- This federal contract award is for the delivery of Clonidine HCL ER 0.1 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,415.58 firm fixed price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corporation, as a child award under the company's Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999. The contract has an ultimate completion date of October 15, 2024 and does not utilize a small business set-aside. As a...
- This federal contract award, valued at $1,040.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.1 mg tablets, a medication used in the treatment of various medical conditions. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,528.37 delivery order contract is for the supply of Clonidine HCL ER 0.1 mg tablets to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of January 27, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,093.21, is for the delivery of Clonidine HCL ER 0.1 mg tablets in quantities of 60 per bottle. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,027.41, with an ultimate completion date of October 16, 2024. No set-aside designation was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,912.42, is for the delivery of Clonidine HCL ER 0.1 mg tablets in 60-count packages. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a primary...
- This federal contract award, valued at $3,082.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a generic pharmaceutical product. The contract has an ultimate completion date of October 28, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $22,348.87. The award date is September 16, 2024, and the ultimate completion date is September 17, 2024. This contract is not designated as a set-aside. As a large...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.84 firm fixed-price delivery order is for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a medication used to treat high blood pressure and other medical conditions. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,902.41 firm fixed-price delivery order is for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FE7CJDelivery Order
This federal contract award, valued at $1,021.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Clonidine HCL ER 0.1 mg tablets. The contract is a delivery order with a firm fixed price, and the ultimate completion date is October 18, 2022. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple contracts and indefinite delivery contracts (IDCs) by various federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, to supply a wide range of essential medical commodities such as prescription drugs, vaccines, and medical supplies. These contracts support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award described is not designated as a set-aside, and no information about subcontractors is provided.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/17/22 |